Contact
Header_1077x260px_About_Profil.jpg

Heart failure: SGLT2 inhibitors moving beyond diabetes

What news in the treatment of Type 2 diabetes was presented at EASD 2019?

Applications of iontophoresis in studies investigating microvasculature

Cardiovascular endpoints in trials with glucose-lowering medications

Treatment with SGLT2 inhibitors: is there hope for renal protection?

Novelties in the treatment of Type 2 diabetes presented at the EASD 2017

How do SGLT2 inhibitors improve cardiovascular outcomes?

Medications for type 2 diabetes: a short historical perspective